ALFA FinderBSE filing, NSE: ORCHPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Orchid Pharma Ltd: key numbers
- Share price
- ₹888.00
- Market cap
- ₹5,318 Cr
- Revenue (annual)
- ₹811.3 Cr
- Net profit (annual)
- ₹20.55 Cr
- P/E (TTM)
- 613.5×Sector 43.8×
- Promoter holding
- 74.45%+4.61% QoQ
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Orchid Pharma Ltd
All →Orchid Pharma Board Meeting Date
Orchid Pharma Ltd intimated that its board will meet on November 14, 2026 to consider Q2 and half-year unaudited results. The trading window stays closed until 48 hours after results declaration.
Orchid Pharma Partnership
Orchid Pharma entered a licensing and supply agreement with Laboratorio Libra for Exblifep across nine Latin American markets. The partnership is expected to represent a potential opportunity of about USD 80 million over 10 years.
Orchid Pharma Fund Raise of ₹600 Cr
Orchid Pharma's board approved an enabling resolution to raise funds of up to ₹600 Crore through equity or debt securities via various permissible modes.
- Value
- ₹600.0 Cr
Orchid Pharma Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Orchid Pharma Board Meeting Date
Orchid Pharma has scheduled a board meeting for October 20, 2026, to consider options for raising funds. The company will explore various suitable funding avenues.
Orchid Pharma Other Announcement
Orchid Pharma Ltd has filed its quarterly Shareholding Pattern, providing a routine update on promoter and public shareholding as mandated by SEBI regulations.
Other other announcement announcements
All →Panafic Industrials Other Announcement
Panafic reports full utilisation of Rs.41.06 crore rights issue proceeds with nil deviation. This is the final Monitoring Agency Report for the quarter ended September 30, 2026.
LAPL Automotive Other Announcement
LAPL Automotive reports no deviation in IPO fund utilisation for the half year to September 2026. Rs.1,956 lakh of the Rs.3,239.62 lakh proceeds remains unutilised.
CapitalNumbers Infotech Other Announcement
Capitalnumbers Infotech's Reg 32 statement shows Rs 4,339.73 lakh of IPO proceeds utilised and Rs 4,128.87 lakh unutilised. Allocations were revised by shareholder resolution.
Caliber Mining and Logistics Other Announcement
Caliber Mining filed CARE Ratings' monitoring report on IPO proceeds for July to September 2026. The report records no deviation from the stated objects of the issue.
Kaushalya Logistics Other Announcement
Kaushalya Logistics submitted its half-yearly related party transactions disclosure for the period ended September 30, 2026. Figures are not stated in the letter.
Kshitij Polyline Other Announcement
Kshitij Polyline's monitoring agency report shows no deviation in rights-issue fund use for the quarter ended September 30, 2026. The issue was revised down to ₹18.98 crore.